Aquestive Therapeutics, Inc. (AQST) Key Statistics
$4.00NGM: AQSTMarket Cap $502.05M
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Aquestive Therapeutics, Inc. (AQST), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-6.28
P/B ratioShare price divided by book value per share.
-9.01
P/S ratioMarket value divided by annual revenue.
9.47
PEG ratioP/E divided by the earnings growth rate.
-5.59
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-7.70
EV / RevenueEnterprise value against annual revenue.
8.74
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-14.10%
Free cash flow yieldFree cash flow as a percentage of market value.
-8.97%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
67.04%
Operating marginRevenue left after operating costs.
-97.52%
Net marginRevenue left after every cost, including tax and interest.
-144.63%
Return on equityProfit as a percentage of shareholders’ equity.
243.68%
Return on assetsProfit as a percentage of total assets.
-59.22%
Return on capital employedOperating profit against the capital the business uses.
-45.62%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
7.19
Quick ratioThe same, excluding inventory.
6.74
Cash ratioCash alone against current liabilities.
2.52
Debt to equityTotal borrowings against shareholders’ equity.
-1.04
Debt to assetsTotal borrowings against total assets.
0.82
Interest coverageHow many times operating profit covers the interest bill.
-3.23
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-0.76
Book value per shareShareholders’ equity divided by shares outstanding.
$0.00
Shares outstandingShares currently issued.
0
Market capitalisationShare price times shares outstanding.
$502.05M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$473.09M
EmployeesReported headcount.
142
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
0.00%
Aquestive Therapeutics, Inc. (AQST) statistics — frequently asked questions
What is Aquestive Therapeutics, Inc.'s P/E ratio?
Aquestive Therapeutics, Inc. (AQST) trades on a price-to-earnings ratio of -6.28. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Aquestive Therapeutics, Inc.'s return on equity?
Aquestive Therapeutics, Inc. (AQST) reports a return on equity of 243.68%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Aquestive Therapeutics, Inc. carry?
Aquestive Therapeutics, Inc. (AQST) has a debt-to-equity ratio of -1.04, which compares total borrowings with shareholders' equity.
What is Aquestive Therapeutics, Inc.'s profit margin?
Aquestive Therapeutics, Inc. (AQST) keeps -144.63% of revenue as net profit after every cost, including tax and interest.